JAK2 V617F mutation detection
JAK2 V617F mutation detection-7781
Janus Kinase 2
Tyrosine Kinase mutation
Detection of point mutation (G to T mutation in exon 12 resulting in the V to F amino acid change at position 617) of the human JAK2 gene. This mutation is associated with myeloproliferative disorders.
- Only ONE (1) tube needs to be drawn for any combination of the following tests:
- Calreticulin Exon 9 Assay
- Factor V Leiden Mutation
- Factor 2 Mutation
- Hereditary Hemochromatosis
- JAK2 V617F Mutation Detection
- MTHFR C677T assay
- Immediatley following collection, mix sample by inverting 8 - 10 times to prevent clotting.
Lavender (EDTA), 4mL
Sodium citrate (Na cit) whole blood
Bone marrow in EDTA
Submit specimen in original collection tube, unspun
Lt blue Sodium citrate (NaCit) - 2.7mL
Yellow ACD (A or B)
Molecular Medicare billing request
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.
Ambient (preferred) - 7 days
Refrigerated - 7 days
- Improper label (unlabeled or mislabeled)
- Wrong container (anticoagulant or solution)
- Improper blood/anticoagulant ratio
- Delay in transport
- Improper storage
- Inappropriate timing of collection
- Interfering substances
- Leaking container
Multiplex, Allele-specific Polymerase Chain Reaction (AS-PCR) analyzed by capillary electrophoresis
An interpretive report will be included
The Calreticulin Exon 9 Assay can be ordered as a reflex to a negative JAK2 V617F Mutation Detection. If ordered as a reflex, do not order the individual assay.
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medicare billing request form to notify us of the need for Allina Health Laboratory to bill insurance.